Reproducibility of quantitative systems pharmacology models: current challenges and future opportunities

DC Kirouac, B Cicali, S Schmidt - CPT: pharmacometrics & …, 2019 - Wiley Online Library
The provision of model code is required for publication in CPT: Pharmacometrics & Systems
Pharmacology, enabling quantitative systems pharmacology (QSP) model availability. A …

Intestinal excretion, intestinal recirculation, and renal tubule reabsorption are underappreciated mechanisms that drive the distribution and pharmacokinetic behavior …

D Zhang, C Wei, CECA Hop, MR Wright… - Journal of medicinal …, 2021 - ACS Publications
Drug reabsorption following biliary excretion is well-known as enterohepatic recirculation
(EHR). Renal tubular reabsorption (RTR) following renal excretion is also common but not …

Complete populations of virtual patients for in silico clinical trials

S Sinisi, V Alimguzhin, T Mancini, E Tronci… - …, 2020 - academic.oup.com
Motivation Model-based approaches to safety and efficacy assessment of pharmacological
drugs, treatment strategies or medical devices (In Silico Clinical Trial, ISCT) aim to decrease …

A comprehensive whole-body physiologically based pharmacokinetic drug–drug–gene interaction model of metformin and cimetidine in healthy adults and renally …

N Hanke, D Türk, D Selzer, N Ishiguro, T Ebner… - Clinical …, 2020 - Springer
Background Metformin is a widely prescribed antidiabetic BCS Class III drug (low
permeability) that depends on active transport for its absorption and disposition. It is …

Mechanistic evaluation of the inhibitory effect of four SGLT-2 inhibitors on SGLT 1 and SGLT 2 using physiologically based pharmacokinetic (PBPK) modeling …

Y Zhang, P Xie, Y Li, Z Chen, A Shi - Frontiers in Pharmacology, 2023 - frontiersin.org
Sodium-glucose co-transporter type 2 (SGLT 2, gliflozins) inhibitors are potent orally active
drugs approved for managing type 2 diabetes. SGLT 2 inhibitors exert a glucose-lowering …

Physiologically based pharmacokinetic model combined with reverse dose method to study the nephrotoxic tolerance dose of tacrolimus

L Cai, M Ke, H Wang, W Wu, R Lin, P Huang… - Archives of Toxicology, 2023 - Springer
Nephrotoxicity is the most common side effect that severely limits the clinical application of
tacrolimus (TAC), an immunosuppressive agent used in kidney transplant patients. This …

[HTML][HTML] Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence

L Pozo, F Bello, A Suarez… - World journal of …, 2019 - ncbi.nlm.nih.gov
Cardiovascular diseases (CVDs) remain the leading cause of death in the world and in most
developed countries. Patients with type 2 diabetes mellitus (T2DM) suffer from both …

A physiologically-based quantitative systems pharmacology model for mechanistic understanding of the response to alogliptin and its application in patients with renal …

C Shen, H Xie, X Jiang, L Wang - Journal of Pharmacokinetics and …, 2025 - Springer
Alogliptin is a highly selective inhibitor of dipeptidyl peptidase-4 and primarily excreted as
unchanged drug in the urine, and differences in clinical outcomes in renal impairment …

Mechanistic evaluation of the effect of sodium‐dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus …

K Mori‐Anai, Y Tashima, T Nakada… - … & Drug Disposition, 2020 - Wiley Online Library
Sodium‐dependent glucose transporter (SGLT) 2 is specifically expressed in the kidney,
while SGLT1 is present in the kidneys and small intestine. SGLT2 inhibitors are a class of …

odd skipped-related 2 as a novel mark for labeling the proximal convoluted tubule within the zebrafish kidney

W Yang, X Liu, Z He, Y Zhang, X Tan, C Liu - Heliyon, 2024 - cell.com
The proximal convoluted tubule (PCT) of the kidney is a crucial functional segment
responsible for reabsorption, secretion, and the maintenance of electrolyte and water …